Novartis has been pursuing a legal case aimed at gutting India’s patent law of important public health safeguards since 2006. The law allows companies in India to produce affordable generic medicines on which MSF and other care providers in developing countries heavily rely to do our work. A protest was organised by Indian civil society on World AIDS Day, 1 December 2011, in front of Novartis' Mumbai Office.
Feature story |

Photos from World AIDS Day Action at Novartis offices in Mumbai

HIV/AIDS INTELLECTUAL PROPERTY AND TRADE
Novartis Drop the Case Campaign
India
Photograph by Claudio Tommasini
Novartis has been pursuing a legal case aimed at gutting India’s patent law of important public health safeguards since 2006. The law allows companies in India to produce affordable generic medicines on which MSF and other care providers in developing countries heavily rely to do our work. A protest was organised by Indian civil society on World AIDS Day, 1 December 2011, in front of Novartis' Mumbai Office. Photograph by Claudio Tommasini

Novartis has been pursuing a legal case aimed at gutting India’s patent law of important public health safeguards since 2006. The law allows companies in India to produce affordable generic medicines on which MSF and other care providers in developing countries heavily rely to do our work.

A protest was organised by Indian civil society on World AIDS Day, 1 December 2011, in front of Novartis' Mumbai Office. 

Learn about MSF's "Novartis, Drop the Case! Campaign" that launched in 2006

Novartis has been pursuing a legal case aimed at gutting India’s patent law of important public health safeguards since 2006. The law allows companies in India to produce affordable generic medicines on which MSF and other care providers in developing countries heavily rely to do our work. A protest was organised by Indian civil society on World AIDS Day, 1 December 2011, in front of Novartis' Mumbai Office.
Novartis has been pursuing a legal case aimed at gutting India’s patent law of important public health safeguards since 2006. The law allows companies in India to produce affordable generic medicines on which MSF and other care providers in developing countries heavily rely to do our work. A protest was organised by Indian civil society on World AIDS Day, 1 December 2011, in front of Novartis' Mumbai Office.
A protest was organised by Indian civil society on World AIDS Day, 1 December 2011, in front of Novartis' Mumbai Office.
A protest was organised by Indian civil society on World AIDS Day, 1 December 2011, in front of Novartis' Mumbai Office. Photographs by Claudio Tommasini